3
Human papilloma vir & vaccine-preventable diseases By Zeena Nackerdien

2014 ACOG guidelines on human papilloma virus vaccination

Embed Size (px)

DESCRIPTION

The detailed report is listed on the ACOG site (reference in slide deck).

Citation preview

Page 1: 2014 ACOG guidelines on human papilloma virus vaccination

Human papilloma virus& vaccine-preventable diseases

By Zeena Nackerdien

Page 2: 2014 ACOG guidelines on human papilloma virus vaccination

LOW-RISK HPV & DISEASES

~70% of cervical cancers (HPV 16/18) (1)

Others: 31, 33, 35, 39, 41, 45, 51, 52, 56, 58, 59 & 66 (2)

HPV 18 HPV 16

HIGH-RISK HPV & CANCERS

•Comparison Page LayoutClassification, incidence of types of associated cancers

Benign/low-grade cervical changes,

Ano-genital warts, juvenile or recurrent respiratory

papillomatosis (1)

HPV 11

HPV 6

1. US Centers for Disease Control and Prevention. Manual for the Surveillance of Vaccine-Preventable Diseases - Chapter 5 (5th edition): Human Papillomavirus (HPV) 2011 http://www.cdc.gov/vaccines/pubs/surv-manual/chpt05-hpv.html2. Cutts F.T., Franceschi S., Goldie S. ea. Bulletin of the World Health Organization. Human papillomavirus and HPV vaccines: a review. Volume 85, Number 9, September 2007, 719-726 http://www.who.int/bulletin/volumes/85/9/06-038414/en/#

Page 3: 2014 ACOG guidelines on human papilloma virus vaccination

•Prevention with approved vaccinesACOG recommendations for target populations (3)

“Routinely recommending HPV vaccination as cancer prevention to be co-administered with other vaccines at age 11 years can improve vaccination rates. (3)

Sexually active women (13-26

y)Counseling, some efficacy, ongoing cervical cytology in women ≥21 y

Sexually active women (>26 y)

Vaccine not approved for this purpose; case-by-case off-label use

may provide marginal benefit

Adolescents & young women*Vaccines can be

given, with emphasis on

limited benefits and continued management

Pregnant & lactating women

HPV vaccination during pregnancy

not recommended;

Lactating women can receive either

approved vaccine.

Immunosuppressed patients

Immune response may be less

robust, but disease status is not a

contra-indication

*cervical intracellular epithelial neoplasia or genital warts. The American Committee of Obstetricians and Gynecology (Committee on Adolescent Health Care Opinion): Human Papilloma Virus Vaccination. Number 588 2014. 1. http://www.acog.org/-/media/Committee-Opinions/Committee-on-Adolescent-Health-Care/co588.pdf?dmc=1&ts=20141015T1435561626.4. Perkins RB, Clark JA, Apte G, Vercruysse JL, Sumner JJ, Wall-Haas CL, et al. Missed Opportunities for HPV Vaccination in Adolescent Girls: A Qualitative Study. Pediatrics. 2014 (e-pub)

Bivalent and quadrivalent vaccines